Blueprint Medicines Corp - Company Profile
Powered by 
All the sales intelligence you need on Blueprint Medicines Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Blueprint Medicines Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Blueprint Medicines Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Blueprint Medicines Corp Clinical Trials
Determine Blueprint Medicines Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Blueprint Medicines Corp Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| (VELA) Study of BLU-222 in Advanced Solid Tumors | GDCT0448050 | BLU-222 | Oncology | Breast Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer); Ovarian Cancer; Solid Tumor | Phase I/II | Ongoing, recruiting | Blueprint Medicines Corp |
| Study of BLU-451 in Advanced Cancers With EGFR-Driven NSCLC Harboring Exon 20 Insertion Mutations | GDCT0447998 | BLU-451 | Oncology; Respiratory | Adenocarcinoma; Carcinomas; Lung Cancer; Lung Disease; Malignant Neoplasms; Metastatic Lung Cancer; Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma | Phase I/II | Ongoing, recruiting | Blueprint Medicines Corp |
| Observational Study Evaluating the Long-term Safety and Efficacy of Avapritinib in the First-line Treatment of Patients with Plat-derived Growth Factor Receptor Alpha (PDGFRA) D842v-mutated Gastrointestinal Stromal Tumour (GIST) | GDCT0431143 | avapritinib | Oncology | Gastrointestinal Stromal Tumor (GIST) | Phase I | Planned | Blueprint Medicines Corp |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer